1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Reprieve Cardiovascular, Inc.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2018

Location

MA US

Primary Industry

Medical Devices & Equipment

About

Established in 2018 and based in Massachusetts, US, Reprieve Cardiovascular, Inc. operates as a medical device company that develops and manufactures medical devices, instruments, and technologies used in the diagnosis, treatment, and management of medical conditions and diseases. In September 2018, Reprieve Cardiovascular raised USD 7 million in venture funding led by Abiomed, Inc., and others.
Current Investors
Abiomed, Inc., Sante Ventures, Deerfield Management

Request a demo to show more

Primary Industry
Medical Devices & Equipment
Sub Industries
Monitoring Equipment, Therapeutic Devices
Website
www.reprievecardio.com
Verticals
HealthTech, Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.